Loading...
DOCUMENTS
21
NOTICES
32
MOTS CLES
Inflammatory bowel disease
Venous thromboembolism
Drug
COLON-CANCER
Stricture
MARKER
Intestinal crypts
Monitoring
Small molecules
Resistance
Colorectal cancer Colibactin and lipids
Rituximab plus chlorambucil
Bacteria
Immune cells
Clinical guidelines
HIV
Microbiote
Gene methylation
Epigenetics
Algorithm
Cost effectiveness
Crohn’s disease
MICROBIOTA
IBD
Dysbiose
Survival
Colon
Ulcerative colitis
Upper gastrointestinal tract
DNA methylation
Biomarker
Microbiota
Disability
Rituximab
Genes
Original Article Clinical
Surgery
IL12
Primary sclerosing cholangitis
Colectomy
Inhibitor
Vedolizumab
Effectiveness
RISK
CARCINOGENESIS
MORTALITY
Gene expression
Kidney diseases
IL23
Bactéries
Eradication
Ustekinumab
Immunosuppressant
Contraindication
Crohn's disease
Anti-TNF
Inclusion
Tuberculosis
Tailored therapy
Maintenance therapy
Helicobacter pylori
Inflammatory Bowel Diseases
Patients experience
Dysbiosis
Acceptability
MALT
Méthylation
18 FDG-PET/CT
Over 80s
T1118 translocation
Neoadjuvant chemotherapy
Cancer
Therapeutics
Epigénétiques
Parvimonas micra
Colon cancer
Gènes
PCR
Disease progression
Disease Progression
Colonic epithelial primary cells
Alkylating agents
Anti-TNF agents
Patient-reported outcome
DNA METHYLATION
Inflammatory bowel diseases
Eligibility
Fecal microbiota
Biologics
Colorectal cancer
Endoscopic treatment
Heart disease risk factors
Consensus
Methylation
Résistance
Thérapie ciblée
Screening
Cell adhesion
Safety
Clinical trial
Early detection of Colon Cancer using Molecular Markers and Microbiota , EA 7375 | |
---|---|
Institutions |
UPEC |
Adresse |
Université Paris-Est Créteil Groupe Hospitalier Henri Mondor Service de Gastroentérologie 51 Av Maréchal de Lattre de Tassigny 94010 Créteil cedex |
Courriel |
|
Site Internet |
|
Rattachement(s) |
|
Direction |
Aurélien AMIOT |
Adjoint |
Iradj SOBHANI |
Axe(s) de recherche
|
Le laboratoire axe ses recherches sur le rôle du microbiome intestinal ainsi que des changements épigénétiques dans l'intestin afin :
|
Derniers dépôts
-
Lucas Guillo, Mathieu Uzzan, Laurent Beaugerie, Jean-Marc Gornet, Aurélien Amiot, et al.. Impact of HIV Infection on the Course of Inflammatory Bowel Disease and Drug Safety Profile: A Multicenter GETAID Study. Clinical Gastroenterology and Hepatology, 2022, 20 (4), pp.787-797.e2. ⟨10.1016/j.cgh.2020.12.023⟩. ⟨hal-04168380⟩
-
Iradj Sobhani, Emma Bergsten, Cecile Charpy, Mathias Chamaillard, Denis Mestivier. Virulent Bacteria as Inflammatory and Immune Co-Factor in Colon Carcinogenesis: Evidence From Two Monozygotic Patients and Validation in CRC Patient and Healthy Cohorts. Frontiers in Cellular and Infection Microbiology, 2021, 11, pp.749750. ⟨10.3389/fcimb.2021.749750⟩. ⟨hal-04543208⟩
-
Lucas Guillo, Guillaume Savoye, Aurélien Amiot, Cyrielle Gilletta, Maria Nachury, et al.. Prevalence of and factors associated with extraintestinal manifestations and their remission in inflammatory bowel disease: the EXTRA prospective study from the GETAID. Clinical and translational gastroenterology, 2023, 14 (12), pp.e00607. ⟨10.14309/ctg.0000000000000607⟩. ⟨hal-04206330⟩
-
Florence Canouï-Poitrine, Astrid Lièvre, Florent Dayde, Daniel Lopez-Trabada-Ataz, Isabelle Baumgaertner, et al.. Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort Survey. Oncologist, 2019, 24 (12), pp.e1351-e1359. ⟨10.1634/theoncologist.2019-0166⟩. ⟨hal-04126614⟩
-
Maria Nachury, Yoram Bouhnik, Mélanie Serrero, Jerome Filippi, Xavier Roblin, et al.. Patients’ real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group. Digestive and Liver Disease, 2021, 53 (4), pp.434-441. ⟨10.1016/j.dld.2020.10.020⟩. ⟨hal-03038260⟩
-
Julien Tap, Aurélien Amiot, Véronique Jarrousse, Sandra Guilmeau, Jeanne Tran Vannhieu, et al.. Early Phenotypical Changes Induced By Transfer Of Human Fecal Microbiota from Colorectal Cancer Patients To Germ-Free Mice. International Journal of Cancer and Oncology, 2017, 4 (1), pp. 1-11. ⟨10.15436/2377-0902.16.1128⟩. ⟨hal-03825702⟩
-
Nicolas Petitdidier, Laurent Beaugerie, Franck Carbonnel, Anne Bourrier, Xavier Treton, et al.. Real-world use of therapeutic drug monitoring of CT-P13 in patients with inflammatory bowel disease: A 12-month prospective observational cohort study. Clinics and Research in Hepatology and Gastroenterology, 2020, 44, pp.609 - 618. ⟨10.1016/j.clinre.2019.11.008⟩. ⟨hal-03492351⟩